JC: Oxygen in ACS. A fuss about nothing? The DETO2X Trial at St.Emlyn’s
Does routine oxygen improve outcomes in suspected acute coronary syndromes? This 2017 appraisal of DETO2X-SWEDEHEART examines its patient selection, unexpectedly low event rate and mortality findings, explaining why a non-significant result does not establish that two treatments are equivalent.
JC: Oxygen in ACS. A fuss about nothing? The DETO2X Trial at St.Emlyn’s Read More